(Irgacure-2959, Ciba-Geigy, 0.1 wt-%) exposed to UV light for 1 h at room temperature using 15 a CL-1000L cross-linker (UVP, USA), providing 5.2 mW/cm 2 (λ = 365 nm) at the surface. 16
The treated titanium ports were removed from the solution and rinsed extensively several 17 times with ethanol and water. 18 
19
In vitro bacterial adhesion on unmodified and modified silicone or titanium 20 disassembled parts of TIVAP. In vitro adhesion properties of modified and unmodified 21 silicone or titanium surfaces were assessed using classical adhesion assay with fluorescently 22 labeled S. aureus Xen36 or P. aeruginosa Lm1. Bacterial densities were calculated by 23 counting bacteria per image using Image-Pro Plus (Media Cybernetics). The detailed 24 experiments is described in Supplementary Methods. hypothesized that modifying TIVAP with polysaccharides or polyethylene glycol could 4 inhibit protein and cellular adhesion. However, one major challenge in using polymers to 5 engineer anti-adhesive surfaces in biomedical devices lies in achieving total high-density 6 surface modifications of the different materials composing the device. TIVAP is composed of 7 a titanium port closed with a silicone septum and is connected to a catheter made of silicone 8 elastomer (PDMS). To ensure chemical modification of the entire commercial device, we 9 completely disassembled the TIVAP to enable surface treatment adapted to each material 10 (PDMS or titanium) of its components (Fig. 1) . First, we used a MeCe derivative bearing 11 alkene groups to modify the inner and outer surface of the septum and catheter made in (Table S1 ). We modified the titanium reservoir surface extracted from the port in 19 two steps, with first the formation of an alkene-terminated self-assembled monolayer (SAM) 20 by liquid phase deposition of undecenyltrichlorosilane, followed by the immobilization of the 21 polyethylene glycol derivative 2 via a thiol-ene reaction (number-average molecular mass 22
Mn ≈ 5 000 daltons) [34] . Surface analysis of the polyethylene glycol-terminated SAM by 23 high-resolution XPS of the C 1s core level region exhibited two features: the first, at 285.0 24 eV, was characteristic of internal units of the polymethylene chain (-CH 2 CH 2 CH 2 -); the9 second, at 286.8 eV, corresponded to methylene groups adjacent to an oxygen (-OCH 2 -) 1 (Supplementary Fig. S2 ). Integration of these signals indicated that the surface density of 2 polyethylene glycol is 0.13 chains/nm 2 . Bacterial growth was observed even at high polymer concentration 1 mg/mL with P. 12 aeruginosa (Lm1) and S. aureus (Xen36), whereas the minimal inhibitory concentration of 13 chlorhexidine was 8 µg/mL for both bacterial strains. The MeCe-modified catheter had no 14 measurable zones of growth inhibition when they were placed on agar plates inoculated with 15 the same bacterial strains. Moreover, the two tested polymers were not cytotoxic to fibroblast 16 L929 cell cultures (100 µg/mL final concentration). with PEG derivative 2. After 24 h of static contact, both P. aeruginosa and S. aureus adhesion 22
to MeCe-and PEG-modified materials was strongly reduced compared to unmodified TIVAP 23 materials (75-to 480-fold reduction, Fig. 2A-E) . We then decided to evaluate the ability of 24
MeCe and PEG modifications to inhibit subsequent steps in bacterial adhesion leading to 25 biofilm formation on fully reconstituted TIVAP. We adopted a previously developed in vitro 1 continuous flow system, using TIVAP to grow biofilm of bioluminescent P. aeruginosa and 2 S. aureus strains for 48 h [31]. Both P. aeruginosa and S. aureus developed high-cell-density 3 biofilms on non-modified TIVAP, as indicated by high luminescent signals (Fig. 2FG) , which 4 correlated with high colony-forming unit (CFU) counts (Fig. 2H) . In contrast, MeCe 5 derivative 1 modified TIVAP (septum+catheter, Si) showed strongly reduced biofilm 6 formation, as indicated by the absence of luminescence signals, which was further confirmed 7 by a marked reduction (~ 7-log) in CFU counts obtained for both P. aeruginosa and S. aureus 8 (Fig. 2H) . Further modifications in the titanium part by PEG derivative 2 (Si-Ti) did not 9 increase the anti-adhesive effect, suggesting that in vitro biofilm formed on the titanium part 10 of the TIVAP is negligible when compared to biofilm formed on silicone parts (Fig. 2H) . 11
12
MeCe and PEG grafting strongly inhibits bacterial biofilm colonization in TIVAP 13 implanted in rats. We tested the in vivo efficacy of the modified TIVAP using a previously 14 described clinically relevant in vivo rat model of biofilm-associated infection in a TIVAP 15 endoluminal surface. For this, the inoculum was left to dwell in the implanted TIVAP for 1 h 24 or 3.5 h for P. aeruginosa and S. aureus, respectively. The rats were euthanized, non-adherent 25 planktonic bacteria were removed from the implanted TIVAP and we determined the quantity 1 of bacteria adhering to the endoluminal part of the explanted TIVAP (Fig. 3A) . Coating of the 2 PDMS parts of TIVAP with MeCe derivative 1 led to a twofold reduction in both S. aureus 3 and P. aeruginosa adherence. Additional coating of the titanium part with PEG derivative 2 4 further reduced initial adhesion of the two bacteria. These results demonstrated that despite 5 prolonged contact of the TIVAP with host proteins, modification of TIVAP by derivatives 1 6 and 2 was still capable of strongly inhibiting initial adhesion of two major biofilm-forming 7 pathogens. We then evaluated the effect of these coatings on later stages of biofilm formation 8 by monitoring TIVAP colonization for 5 days (Fig. 3B-H) . While bioluminescence signals 9 appeared at day 1 for uncoated TIVAP infected with both S. aureus and P. aeruginosa, no S. MeCe-coated TIVAP prevented biofilm-associated clogging in all coated TIVAP. Similarly, 10 the number of patent TIVAP increased to 78% when MeCe-coated TIVAP were infected with 11 S. aureus as compared to non-coated TIVAP, that showed only 10% patency ( Table 1) . In 12 order to confirm that the loss of patency in implanted devices was due to biofilm formation, 13
we performed electron microscopy imaging on coated and non-coated TIVAP isolated after 5 14 days of infection (Fig. 4) . Scanning electron microscopy analysis clearly demonstrated the 15 massive and distinct rod-like biofilm structures formed in the endoluminal part of catheters 16 from non-coated TIVAP. These biofilms were associated with the presence of high numbers 17 of host cells (red blood cells, platelets) entangled in a dense fibrin network likely leading to 18 device occlusion. In contrast, catheters from TIVAP that received the MeCe graft showed 19 many fewer bacteria and host cells scattered on the surface of the device (Fig. 4) , thereby 20 pointing to the efficiency of MeCe coating at reducing in vivo host cell, protein and bacterial 21 cell interactions with the luminal part of the catheter. 22 supportive therapy and blood sampling over a long period of time. However, the interaction 3 between the implant and surrounding tissues can lead to complications such as thrombosis 4 and infections due to the hydrophobic nature of the material composing most medical devices. 5
Suppression of such deleterious interactions via an anti-adhesive strategy is of particular 6 interest by offering a universal solution so as to avoid medical complications, while also 7 preventing the emergence of drug resistance. However, the efficiency of such anti-adhesive 8 strategy in the case of fully functional implantable medical devices must be demonstrated in 9 vivo, a setting in which coated surfaces can become conditioned by host factors, reducing its 10 efficacy. In this study, we demonstrate an anti-adhesive strategy developed using a rational 11 design by grafting, in solution, a monolayer of polymers on the surface of a commercial 12 TIVAP: methylcellulose (MeCe) 1 on the septum and the catheter and polyethylene glycol 13 We show that the efficiency of the developed coating was partly due to its capacity to reduce 3 initial adhesion of both S. aureus and P. aeruginosa biofilm-forming pathogens. In light of 4 the previously described anti-fouling activity of methylcellulose against host proteins and cell 5 adhesion [30], and its herein excellent in vivo anti-biofilm efficacy, we also hypothesized that 6 this coating could present strong anti-clogging activity. Consistent with the fact that occlusion 
